New uses for milk-derived products for eradication of Helicobacter pylori infection and gastro-intestinal site-specific delivery of active agents. Helicobacter pylori is the most significant bacterial pathogen in the world, infecting 50% globally. Current treatments are inducing rapid antibiotic resistance and are thus becoming increasingly less effective. The infection is acquired in childhood and new methods to prevent and/or treat the infection, minimising acquisition of antibiotic resistance ....New uses for milk-derived products for eradication of Helicobacter pylori infection and gastro-intestinal site-specific delivery of active agents. Helicobacter pylori is the most significant bacterial pathogen in the world, infecting 50% globally. Current treatments are inducing rapid antibiotic resistance and are thus becoming increasingly less effective. The infection is acquired in childhood and new methods to prevent and/or treat the infection, minimising acquisition of antibiotic resistance are urgently required. This project seeks to develop new ways of doing this that combine novel antibacterials with techniques to deliver them (and monitor this delivery) as well as modify the complex protective habitat in the stomach.Read moreRead less
Towards early detection of upper airway obstruction in children: investigation of autonomic control. This project focuses on the investigation of new indicators for early detection of upper airway obstruction (UAO)-which is a common sleep disorder in children. Failure to treat UAO can result in serious adverse outcomes including failure to thrive, neurocognitive deficits, developmental delay, behavioural disorders and cardiovascular disease. Thus, early treatment of UAO will significantly improv ....Towards early detection of upper airway obstruction in children: investigation of autonomic control. This project focuses on the investigation of new indicators for early detection of upper airway obstruction (UAO)-which is a common sleep disorder in children. Failure to treat UAO can result in serious adverse outcomes including failure to thrive, neurocognitive deficits, developmental delay, behavioural disorders and cardiovascular disease. Thus, early treatment of UAO will significantly improve quality of life for the child. Direct benefits to community health via reduced costs for medical treatment will also be a key outcome. The establishment of new diagnostic indicators will form the basis of new tools for identifying child sleep disorders and contribute to advancing Australia's international leading position in health technology. Read moreRead less
Combining the soft with the hard: The assembly of artificial cell membranes on porous semiconductors. The platform technologies developed in this project will have a wide range of applications. They will reveal new insights into drug-membrane and drug-protein interactions underpinning development of a new generation of drugs acting on transmembrane proteins that are linked to a wide range of diseases. The development of membrane-based biosensing devices targeting ion channels, membrane active pe ....Combining the soft with the hard: The assembly of artificial cell membranes on porous semiconductors. The platform technologies developed in this project will have a wide range of applications. They will reveal new insights into drug-membrane and drug-protein interactions underpinning development of a new generation of drugs acting on transmembrane proteins that are linked to a wide range of diseases. The development of membrane-based biosensing devices targeting ion channels, membrane active peptides or toxins which can be applied to biomedical diagnostics, biotoxin detection, environmental and food control will be readily achievable. This international interdisciplinary nanobiotechnology programme and its outcomes will enhance Australia's abilities in frontier technologies and build research strength in nanobiotechnology.Read moreRead less